Expanded Access to PCNAT-01 for Patients With Resected Pancreatic Ductal Adenocarcinoma Following Surgical Resection and Adjuvant Therapy
Clinical trial NCT07612930 · AVAILABLE
Trial details
- NCT number
- NCT07612930
- Sponsor
- Anda Biopharmaceutical Development (Shenzhen) Co., Ltd.
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.